Company Filing History:
Years Active: 2023
Title: Hossam S El-Sawy: Innovator in Buccal Formulations
Introduction
Hossam S El-Sawy is a notable inventor based in Cairo, Egypt. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of buccal tablets. His innovative work focuses on enhancing the bioavailability and duration of medications.
Latest Patents
Hossam S El-Sawy holds a patent for a buccal formulation of avanafil with enhanced bioavailability and prolonged duration. This formulation includes a combination of polyvinylpyrrolidone K-90 as a solid dispersion polymer, hydroxypropyl methylcellulose as a mucoadhesive polymer, sodium deoxycholate as a mucopenetration enhancer, porous silicon dioxide, mannitol, and avanafil. The ratio of PVP K-90 to avanafil in the tablet is approximately 2:1, specifically ranging from 2.3:1 to 1.7:1. The patent also outlines methods for creating the buccal tablet and its application in treating erectile dysfunction.
Career Highlights
Hossam S El-Sawy is affiliated with King Abdulaziz University, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on the treatment of erectile dysfunction through innovative drug delivery systems.
Collaborations
Hossam has collaborated with notable colleagues, including Omar D Al-hejaili and Khalid Mohamed El-Say, contributing to a dynamic research environment that fosters innovation and development in pharmaceutical sciences.
Conclusion
Hossam S El-Sawy's contributions to buccal formulations represent a significant advancement in pharmaceutical technology. His innovative approach to enhancing drug delivery systems has the potential to improve patient outcomes in the treatment of erectile dysfunction.